Enovis Corporation ENOV
18.46
0.19
1.04%
as of 25 Sep
- Market cap
- $1.1B
- P/E
- 0.0×
Follow ENOV
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.78 | 0.68 | 0.57 | 0.52 | |
P/FCF ratio |
76.19 | 76.33 | 36.30 | 18.73 | |
P/Operating CF |
21.01 | 17.17 | 54.44 | 15.89 | |
P/B ratio |
0.86 | 1.02 | 0.88 | 0.81 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.37 | 1.24 | 1.14 | 1.07 | |
EV/EBITDA |
15.02 | 12.65 | 9.44 | 7.98 | |
EV/Operating CF |
14.10 | 12.80 | 10.69 | 9.12 | |
EV/FCF |
134.43 | 139.62 | 72.29 | 38.71 | |
Quick Ratio |
0.81 | 0.80 | 0.78 | 0.74 | |
Current Ratio |
2.22 | 2.02 | 2.04 | 1.98 | |
Net Debt/EBITDA |
20.61 | 16.55 | 16.18 | 14.38 | |
Debt/Assets |
30.67% | 33.82% | 34.60% | 34.11% | |
Debt/Equity |
0.67 | 0.87 | 0.90 | 0.87 | |
Asset Turnover |
0.45 | 0.53 | 0.52 | 0.52 | |
Operating CF/Net income |
(0.14) | (0.17) | (2.73) | (63.05) | |
Capex/Depreciation |
(0.09) | (0.10) | (0.72) | (0.62) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
5.42% | 5.45% | 5.35% | 5.44% | |
Selling, General and Administrative Expense of Revenue |
48.03% | 46.97% | 48.00% | 45.25% | |
Intangible Assets out of Total Assets |
0.56 | 0.51 | 0.50 | 0.49 | |
Share Based Compensation of Revenue |
1.59% | 1.41% | 1.49% | 1.54% | |
Graham Net Nets |
(0.65) | (0.75) | (0.85) | (0.90) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(77.98%) | (77.74%) | (87.38%) | (93.04%) | |
Free Cash Flow Yield |
1.31% | 1.31% | 2.76% | 5.34% | |
Revenue per Share |
9.60 | 10.09 | 10.28 | 10.12 | |
Operating CF per Share |
1.44 | 1.55 | 0.42 | 1.30 | |
Capex per Share |
(0.94) | (0.99) | (0.92) | (0.76) | |
Free Cash Flow per Share |
0.51 | 0.57 | (0.50) | 0.54 | |
Cash per Share |
0.59 | 0.64 | 0.58 | 0.22 | |
Shareholders Equity per Share |
35.40 | 26.14 | 25.81 | 25.68 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
35.40 | 26.14 | 25.81 | 25.68 | |
Free Cash Flow |
29.09 | 32.29 | (28.85) | 31.14 | |
Working Capital |
704.68 | 608.59 | 631.02 | 602.64 | |
Capital Expenditures |
(53.49) | (56.25) | (52.80) | (43.89) | |
Net Current Asset Value |
(1,129.56) | (1,135.78) | (1,113.08) | (1,072.27) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.10 | 0.10 | 0.09 | 0.08 | |
Net Profit Margin |
(104.05%) | (90.42%) | (1.49%) | (0.20%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
415.99 | 424.91 | 439.91 | 447.77 | |
Average Payables |
178.41 | 183.31 | 200.89 | 203.24 | |
Average Inventory |
611.71 | 565.75 | 594.23 | 614.94 | |
Average Assets |
4,991.75 | 4,276.76 | 4,353.65 | 4,393.76 | |
Average Common Equity |
2,678.49 | 2,028.12 | 2,049.86 | 2,030.06 |
Columns are period end dates